Omeros Corp (OMER)
3.075
-0.01
(-0.32%)
USD |
NASDAQ |
Apr 23, 16:00
3.075
0.00 (0.00%)
After-Hours: 17:02
Omeros Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 58.99% |
| September 30, 2020 | -147.3% |
| June 30, 2020 | -246.1% |
| March 31, 2020 | -123.3% |
| December 31, 2019 | 37.28% |
| September 30, 2019 | -55.14% |
| June 30, 2019 | -54.02% |
| March 31, 2019 | -111.8% |
| December 31, 2018 | -106.9% |
| September 30, 2018 | -856.6% |
| June 30, 2018 | -2.04K% |
| March 31, 2018 | -1.89K% |
| December 31, 2017 | -120.3% |
| September 30, 2017 | -34.55% |
| June 30, 2017 | -83.72% |
| March 31, 2017 | -123.1% |
| December 31, 2016 | -152.1% |
| September 30, 2016 | -123.7% |
| June 30, 2016 | -126.1% |
| March 31, 2016 | -276.8% |
| December 31, 2015 | -297.0% |
| September 30, 2015 | -611.3% |
| June 30, 2015 | -523.4% |
| March 31, 2015 | -4.81K% |
| December 31, 2014 | -11.51K% |
| Date | Value |
|---|---|
| September 30, 2014 | -8.56K% |
| June 30, 2014 | -39.98K% |
| March 31, 2014 | -16.64K% |
| December 31, 2013 | -1.09K% |
| September 30, 2013 | -7.08K% |
| June 30, 2013 | -9.71K% |
| March 31, 2013 | -957.9% |
| December 31, 2012 | -488.6% |
| September 30, 2012 | -936.9% |
| June 30, 2012 | -559.6% |
| March 31, 2012 | -594.6% |
| December 31, 2011 | -892.5% |
| September 30, 2011 | -659.8% |
| June 30, 2011 | -458.1% |
| March 31, 2011 | -528.0% |
| December 31, 2010 | -740.9% |
| September 30, 2010 | -2.97K% |
| June 30, 2010 | -1.57K% |
| March 31, 2010 | -1.76K% |
| December 31, 2009 | -1.29K% |
| September 30, 2009 | -886.0% |
| June 30, 2009 | -1.65K% |
| March 31, 2009 | -2.78K% |
| December 31, 2008 | -3.53K% |
| September 30, 2008 | -1.47K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-246.1%
Minimum
Jun 2020
58.99%
Maximum
Dec 2020
-75.66%
Average
-55.14%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
| Aspira Womens Health Inc | -145.0% |
| Ardelyx Inc | -83.82% |
| Panbela Therapeutics Inc | -- |
| Ensysce Biosciences Inc | -- |
| MAIA Biotechnology Inc | -- |